Comprehensive turnkey system based on industry-leading LabVantage LIMS platform allows laboratories to implement COVID-19 biobanking, testing, and research almost immediately
Under the agreement, Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19
Improved testing platforms with greater specificity, throughput, and environmental testing capabilities are essential to support public health decisions
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
PrecisionLife is now offering free use of its unique analytics platform and support from its data and biomedical science teams to those involved in COVID-19 research
Findings could explain why some COVID-19 patients experience gastrointestinal symptoms, and the fact that the virus often can be detected in stool samples